THYROTROPIN RECEPTOR ANTIBODY ACTIVITIES SIGNIFICANTLY CORRELATE WITH THE OUTCOME OF RADIOIODINE (I-131) THERAPY FOR HYPERTHYROID GRAVES-DISEASE

The outcome of I-131 therapy for 109 patients with Graves' disease was analysed according to pretreatment laboratory data including thyrotropin receptor antibody (TRAb) activities. Forty-five percent of patients became euthyroid, and 13% of patients became hypothyroid within one year after I-131 therapy. Forty-two percent of patients remained hyperthyroid one year after I-131 therapy. Pretreatment values for serum T4, T3, and the estimated weight of the thyroid were significantly higher in the hyperthyroid group. The mean for the TRAb index of the hyperthyroid group was significantly higher-than-that of the euthyroid group. Life table analysis revealed a significant effect of the TRAb index on the rate of hyperthyroidism after 3 months or later. These results appear to suggest that the TRAb index is one of the factors which influence the outcome of I-131 therapy for Graves' disease.